X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (27) 27
hematology (26) 26
index medicus (25) 25
male (21) 21
transplantation (20) 20
female (18) 18
adult (16) 16
adolescent (15) 15
immunology (15) 15
article (14) 14
child (12) 12
middle aged (12) 12
hematopoietic stem cells (11) 11
hematology, oncology and palliative medicine (10) 10
versus-host-disease (10) 10
aged (9) 9
bone-marrow-transplantation (9) 9
hematologic malignancies (9) 9
transplantation, homologous (9) 9
cancer (8) 8
child, preschool (8) 8
health aspects (8) 8
hematopoietic stem cell transplantation - adverse effects (8) 8
hematopoietic stem cell transplantation - methods (8) 8
oncology (8) 8
total-body irradiation (8) 8
transplantation conditioning - methods (8) 8
treatment outcome (8) 8
young adult (8) 8
bone marrow (7) 7
hematopoietic stem cell transplantation (7) 7
infant (7) 7
research (7) 7
transplantation conditioning (7) 7
animals (6) 6
graft vs host disease - etiology (6) 6
medical colleges (6) 6
prognosis (6) 6
recurrence (6) 6
care and treatment (5) 5
cyclosporine (5) 5
disease-free survival (5) 5
hematologic neoplasms - therapy (5) 5
hematopoietic cell transplantation (5) 5
hemic and lymphatic diseases (5) 5
histocompatibility testing (5) 5
leukemia (5) 5
oncology, experimental (5) 5
pediatrics (5) 5
stem cells (5) 5
stem-cell transplantation (5) 5
surgical procedures, operative (5) 5
survival analysis (5) 5
unrelated donors (5) 5
antithymocyte globulin (4) 4
bone-marrow (4) 4
children (4) 4
cyclophosphamide (4) 4
graft vs host disease - prevention & control (4) 4
mortality (4) 4
mycophenolic acid - analogs & derivatives (4) 4
myeloablative agonists - therapeutic use (4) 4
outcomes (4) 4
risk (4) 4
therapy (4) 4
acute disease (3) 3
acute myeloid-leukemia (3) 3
analysis (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
aplastic anemia (3) 3
bone marrow transplantation - methods (3) 3
bone-marrow transplantation (3) 3
conditioning regimen (3) 3
disease progression (3) 3
flow cytometry (3) 3
follow-up studies (3) 3
graft rejection (3) 3
graft-versus-host disease (3) 3
hematopoietic-cell transplantation (3) 3
immunosuppressive agents - therapeutic use (3) 3
incidence (3) 3
mutation (3) 3
mycophenolic acid - administration & dosage (3) 3
retrospective studies (3) 3
syndrome (3) 3
t cells (3) 3
t-cells (3) 3
transplantation chimera (3) 3
usage (3) 3
vidarabine - analogs & derivatives (3) 3
vidarabine - therapeutic use (3) 3
whole-body irradiation (3) 3
abridged index medicus (2) 2
acute lymphoblastic-leukemia (2) 2
acute myeloid leukemia (2) 2
allogeneic stem cell transplantation (2) 2
allogeneic transplantation (2) 2
anemia (2) 2
anemia, aplastic - complications (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2017, Volume 23, Issue 10, pp. 1669 - 1677
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2010, Volume 126, Issue 5, pp. 1000 - 1005
Background Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome is characterized by severe systemic autoimmunity caused by mutations... 
Allergy and Immunology | regulatory T cells | Hematopoietic cell transplantation | autoimmunity | immune reconstitution | immunodeficiency | nonmyeloablative conditioning regimen | immune dysregulation | Autoimmunity | Immune dysregulation | Immunodeficiency | Immune reconstitution | Nonmyeloablative conditioning regimen | Regulatory T cells | FOXP3 EXPRESSION | DIARRHEA | BONE-MARROW-TRANSPLANTATION | IPEX SYNDROME | IMMUNOLOGY | VERSUS-HOST-DISEASE | ALLERGY | T-CELLS | Graft vs Host Disease - therapy | Myeloablative Agonists - therapeutic use | Whole-Body Irradiation | Humans | Immunosuppressive Agents - therapeutic use | Infant | Male | Flow Cytometry | Hematopoietic Stem Cell Transplantation - adverse effects | Genetic Diseases, X-Linked - genetics | Transplantation Conditioning - methods | Child | Graft vs Host Disease - etiology | Genetic Diseases, X-Linked - physiopathology | Immunologic Deficiency Syndromes - therapy | Cell Separation | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Forkhead Transcription Factors - genetics | Reverse Transcriptase Polymerase Chain Reaction | Syndrome | Graft vs Host Disease - pathology | Cyclosporine - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Immunologic Deficiency Syndromes - physiopathology | Adolescent | Immunologic Deficiency Syndromes - genetics | Hematopoietic Stem Cell Transplantation - methods | Genetic Diseases, X-Linked - therapy | Medical colleges | Granulocyte colony-stimulating factor | Oncology, Experimental | Transplantation | Research | Macrophage colony stimulating factor | Hematopoietic stem cells | Cancer | Bone marrow | Mutation | Transplants & implants | Mortality | Stem cells | Index Medicus | Abridged Index Medicus | Regulatory T-cells
Journal Article
American Journal of Hematology, ISSN 0361-8609, 03/2016, Volume 91, Issue 3, pp. 322 - 329
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2014, Volume 20, Issue 1, pp. 89 - 97
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2012, Volume 18, Issue 9, pp. 1446 - 1454
Allogeneic hematopoietic cell transplantation (HCT) is curative for selected patients with advanced essential thrombocythemia (ET) or polycythemia vera (PV).... 
Hematology, Oncology and Palliative Medicine | Transplantation | PV | ET | MYELOFIBROSIS | RISK-FACTORS | MARROW | HYDROXYUREA | ACUTE MYELOID-LEUKEMIA | IMMUNOLOGY | PHASE | MUTATION | CURATIVE THERAPY | JAK2 | HEMATOLOGY | MYELODYSPLASTIC SYNDROMES | Myeloablative Agonists - therapeutic use | Recurrence | Humans | Middle Aged | Male | Graft vs Host Disease - immunology | Polycythemia Vera - mortality | Transplantation, Homologous | Splenectomy | Polycythemia Vera - complications | Splenomegaly - complications | Splenomegaly - therapy | Thrombocythemia, Essential - immunology | Splenomegaly - mortality | Adult | Female | Acute Disease | Splenomegaly - immunology | Neutrophils - immunology | Hematopoietic Stem Cell Transplantation | Polycythemia Vera - therapy | Thrombocythemia, Essential - mortality | Survival Analysis | Thrombocythemia, Essential - therapy | Graft vs Host Disease - prevention & control | Transplantation Conditioning | Longitudinal Studies | Polycythemia Vera - immunology | Thrombocythemia, Essential - complications | Autoimmunity | Medical colleges | Polycythemia | Oncology, Experimental | Bone marrow | Research | Hematopoietic stem cells | Biometry | Cancer | Splenomegaly | Neutrophils | Myeloablative Agonists | Thrombocythemia, Essential | Graft vs Host Disease | Life Sciences | Polycythemia Vera
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2013, Volume 31, Issue 12, pp. 1530 - 1538
Journal Article
Haematologica, ISSN 0390-6078, 08/2011, Volume 96, Issue 8, pp. 1113 - 1120
Journal Article
Journal Article
Haematologica, ISSN 0390-6078, 10/2014, Volume 99, Issue 10, pp. 1624 - 1631
Journal Article